Advertisement

Differences in Treatment Goals and Perception of Symptom Burden Between Patients With Myeloproliferative Neoplasms (MPNs) and Hematologists/Oncologists in the United States: Findings from the MPN Landmark Survey

This analysis of the myeloproliferative neoplasm (MPN) Landmark Survey evaluated gaps between patient perceptions of their disease management and physician self-reported practices.

 Cancer